Prof. Catherine Creuzot-Garcher
Professor of Ophthalmology and Chair, University Hospital of Dijon, France
Catherine Creuzot-Garcher is currently Head of the Department of Ophthalmology and is responsible for the outpatient surgical unit at the University Hospital of Dijon, France.
She is a member of the teaching council of the faculty and has been strongly involved in European teaching programs of the European Board of Ophthalmology (EBO) as the French delegate (2004–16). She was Chairman of the Education Committee of the EBO and President of the EBO from 2013 to 2015. She is the French delegate for European University Professors of Ophthalmology (EUPO). Professor Creuzot-Garcher was also President of the Collège des Ophtalmologistes Universitaries de France (COUF) for 8 years and has been a council member of the Société Française d'Ophtalmologie (SFO) since May 2009. She was Vice-Secretary General of the SFO in 2013–15 and President of the SFO in 2016. She was also Secretary General of the European Association for Vision and Eye Research from 2012 to 2016.
She is co-director of the eye, nutrition and signalisation unit of INRA Centre, Dijon. As Head of the Research Pole at the University Hospital since 2012, she deals with all research programs at the hospital and has been coordinator of three national clinical trials (PHRC) dedicated to retinal detachment (DOREFA), diabetic retinopathy (LIGHT), and type 1 macular telangiectasia (TELEMAC) and two regional trials dedicated to endophthalmitis and macular subretinal hemorrhage. She is a consultant for Haute Autorité de Santé and expert adviser for the French Ministry of Health (ANSM) for dry eye disease, allergy, nutrition, age-related macular degeneration (AMD), and diabetic retinopathy since 1999.
She was awarded Chevalier des Palmes Académiques in 2011 and Chevalier de la Légion d’Honneur in 2013.
To date, she has been involved in the development of 220 papers published in peer-reviewed journals and 15 books, and her main fields of interest are surgical retina, diabetic retinopathy, and AMD.